In addition, the expression of both MMP-2 and MMP-9 was significantly decreased in the KB oral cancer cells that had been co-stimulated with berberine and the p38 MAPK-specific chemical inhibitor compared to those that had been treated with berberine only (Fig. 4D). This evidence concerns the gene MMP9 and lip and oral cavity carcinoma.